EICHOR About Solutions

Recruiting studies: Advanced Or Metastatic Solid Malignancies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
Phase 1 · 9 location(s) · Avacta Life Sciences Ltd · NCT04969835 A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Ac
Phase 1/Phase 2 · 74 location(s) · Nuvalent Inc. · NCT05384626 A Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
Phase 1/Phase 2 · 2 location(s) · RemeGen Co., Ltd. · NCT05205850 Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Chinese PLA General Hospital · NCT05693844 Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The K
Phase 4 · 1 location(s) · OHSU Knight Cancer Institute · NCT07405086 A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Met
Phase 1/Phase 2 · 3 location(s) · GI Innovation, Inc. · NCT07172802 Intratumoral CAN2109 in Subjects With Solid Tumors
Phase 1 · 1 location(s) · Canwell Biotech Limited · NCT06332430 Is the 1939 Cancer Act Fit for Purpose in the Modern Technology Era?
Phase N/A · 1 location(s) · Royal Cornwall Hospitals Trust · NCT07584824 A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malign
Phase 1 · 1 location(s) · GigaGen, Inc. · NCT06258304 Phase I Clinical Study of BL-M07D1 in Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors
Phase 1 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT05631964 Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancre
Phase 2 · 1 location(s) · OHSU Knight Cancer Institute · NCT05705492 A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
Phase 1/Phase 2 · 41 location(s) · Alentis Therapeutics AG · NCT06747585 CD8 PET Imaging in Metastatic Solid Tumours
Phase 2 · 4 location(s) · University Medical Center Groningen · NCT06534190 AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 · 1 location(s) · Yale University · NCT07027488 A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid M
Phase 1 · 2 location(s) · Zelluna Immunotherapy AS · NCT07613723 A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
Phase 1 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06493864 Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastati
Phase 2 · 27 location(s) · National Cancer Institute (NCI) · NCT06311214 A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other
Phase 1 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT07232407 A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTR
Phase 1/Phase 2 · 6 location(s) · Cullgen (Shanghai),Inc · NCT07394374 A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Canc
Phase 1 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06500052 A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors
Phase 1/Phase 2 · 12 location(s) · A2 Biotherapeutics Inc. · NCT06051695 HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Chinese PLA General Hospital · NCT05681650 Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced S
Phase 1/Phase 2 · 39 location(s) · ModernaTX, Inc. · NCT05533697 A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Phase 1 · 8 location(s) · ALX Oncology Inc. · NCT07085091 IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
Phase 1 · 5 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT06349408 Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherap
Phase 1/Phase 2 · 4 location(s) · Auricula Biosciences Inc. · NCT07148128 Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors
Phase 1 · 1 location(s) · Zhejiang Doer Biologics Co., Ltd. · NCT06132828 A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorect
Phase 1 · 21 location(s) · Bayer · NCT07535112 ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
Phase 1 · 9 location(s) · Adcytherix SAS · NCT07238075 Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 2 location(s) · Lamassu Bio Inc · NCT06578624

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →